


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+9.60%
-9.82%
-1.00%
-0.49%
+1.01%
SCNI
Scinai Immunotherapeutics
$1.20
Strengths

Earnings are forecast to grow
SCNI Price Performance
$0.96 (+25.00%)
$1.57 (-23.57%)
$2.06 (-41.75%)
$3.36 (-64.29%)
SCNI has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

Low volume

High volatilty

SCNI overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
SCNI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
SCNI Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is SCNI current stock price?
What are SCNI stock strengths?
What is SCNI Risk Level?
What is SCNI market cap and volume?
What is SCNI current Stock IQ?
Should I buy SCNI stock right now?
Is SCNI a Strong Buy right now?
What does a 'Strong Buy' rating mean for SCNI?
What does a 'Strong Sell' rating mean for SCNI?
What factors influence SCNI's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+9.60%
-9.82%
-1.00%
-0.49%
+1.01%
SCNI
Scinai Immunotherapeutics
Current Price
$1.20
Stock Insights
Strengths

Earnings are forecast to grow

SCNI Price Performance
$0.96 (+25.00%)
$1.57 (-23.57%)
$2.06 (-41.75%)
$3.36 (-64.29%)
SCNI Analysts Opinion
SCNI Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
SCNI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
SCNI Street Sentiment is extremely bullish and have positive views on the near-term outlook
SCNI has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

Low volume

High volatilty

Average key support and resistance price levels
SCNI Stock IQ
SCNI Latest Analysis
Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances. Scinai Immunotherapeutics Ltd. (NASDAQ:) (".Scinai". or the ".Company".) a biopharmaceutical company developing innovative inflammation and immunology (I&.I) therapeutics and operating a growing boutique CDMO business unit today reported its financial results and corporate highlights for the nine months ended First Nine Months 2025 Financial SummaryRevenues for the nine months ended . Th
Tue Dec 2, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SCNI Stock trends
SCNI Stock performance
SCNI Stock analysis
SCNI investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.